178 related articles for article (PubMed ID: 19597132)
1. Dopamine cell loss in the periaqueductal gray in multiple system atrophy and Lewy body dementia.
Benarroch EE; Schmeichel AM; Dugger BN; Sandroni P; Parisi JE; Low PA
Neurology; 2009 Jul; 73(2):106-12. PubMed ID: 19597132
[TBL] [Abstract][Full Text] [Related]
2. Rostral raphe involvement in Lewy body dementia and multiple system atrophy.
Benarroch EE; Schmeichel AM; Sandroni P; Parisi JE; Low PA
Acta Neuropathol; 2007 Sep; 114(3):213-20. PubMed ID: 17639427
[TBL] [Abstract][Full Text] [Related]
3. Degeneration of brainstem respiratory neurons in dementia with Lewy bodies.
Presti MF; Schmeichel AM; Low PA; Parisi JE; Benarroch EE
Sleep; 2014 Feb; 37(2):373-8. PubMed ID: 24501436
[TBL] [Abstract][Full Text] [Related]
4. Differential involvement of the periaqueductal gray in multiple system atrophy.
Benarroch EE; Schmeichel AM; Low PA; Parisi JE
Auton Neurosci; 2010 Dec; 158(1-2):111-7. PubMed ID: 20732833
[TBL] [Abstract][Full Text] [Related]
5. Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy.
Schmeichel AM; Buchhalter LC; Low PA; Parisi JE; Boeve BW; Sandroni P; Benarroch EE
Neurology; 2008 Jan; 70(5):368-73. PubMed ID: 18227417
[TBL] [Abstract][Full Text] [Related]
6. TIGAR inclusion pathology is specific for Lewy body diseases.
López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR
Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647
[TBL] [Abstract][Full Text] [Related]
7. Alpha-synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy.
Mori F; Piao YS; Hayashi S; Fujiwara H; Hasegawa M; Yoshimoto M; Iwatsubo T; Takahashi H; Wakabayashi K
J Neuropathol Exp Neurol; 2003 Aug; 62(8):812-9. PubMed ID: 14503637
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylated NUB1 distinguishes α-synuclein in Lewy bodies from that in glial cytoplasmic inclusions in multiple system atrophy.
Tanji K; Miki Y; Mori F; Kon T; Kakita A; Takahashi H; Wakabayashi K
Brain Pathol; 2019 Nov; 29(6):803-812. PubMed ID: 31006160
[TBL] [Abstract][Full Text] [Related]
9. Expanding the spectrum of neuronal pathology in multiple system atrophy.
Cykowski MD; Coon EA; Powell SZ; Jenkins SM; Benarroch EE; Low PA; Schmeichel AM; Parisi JE
Brain; 2015 Aug; 138(Pt 8):2293-309. PubMed ID: 25981961
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of abnormalities of sympathetic tyrosine hydroxylase and alpha-synuclein in chronic autonomic failure.
Isonaka R; Sullivan P; Jinsmaa Y; Corrales A; Goldstein DS
Clin Auton Res; 2018 Apr; 28(2):223-230. PubMed ID: 29396794
[TBL] [Abstract][Full Text] [Related]
11. Abundance of Synaptic Vesicle-Related Proteins in Alpha-Synuclein-Containing Protein Inclusions Suggests a Targeted Formation Mechanism.
McCormack A; Keating DJ; Chegeni N; Colella A; Wang JJ; Chataway T
Neurotox Res; 2019 May; 35(4):883-897. PubMed ID: 30796693
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic and genetic features of multiple system atrophy with Lewy body disease.
Koga S; Li F; Zhao N; Roemer SF; Ferman TJ; Wernick AI; Walton RL; Faroqi AH; Graff-Radford NR; Cheshire WP; Ross OA; Dickson DW
Brain Pathol; 2020 Jul; 30(4):766-778. PubMed ID: 32232888
[TBL] [Abstract][Full Text] [Related]
13. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylated α-synuclein in skin Schwann cells: a new biomarker for multiple system atrophy.
Donadio V; Incensi A; Rizzo G; Westermark GT; Devigili G; De Micco R; Tessitore A; Nyholm D; Parisini S; Nyman D; Tedeschi G; Eleopra R; Ingelsson M; Liguori R
Brain; 2023 Mar; 146(3):1065-1074. PubMed ID: 35552610
[TBL] [Abstract][Full Text] [Related]
15. Involvement of medullary regions controlling sympathetic output in Lewy body disease.
Benarroch EE; Schmeichel AM; Low PA; Boeve BF; Sandroni P; Parisi JE
Brain; 2005 Feb; 128(Pt 2):338-44. PubMed ID: 15634729
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of HtrA2/Omi in neuronal and glial inclusions in brains with alpha-synucleinopathies.
Kawamoto Y; Kobayashi Y; Suzuki Y; Inoue H; Tomimoto H; Akiguchi I; Budka H; Martins LM; Downward J; Takahashi R
J Neuropathol Exp Neurol; 2008 Oct; 67(10):984-93. PubMed ID: 18800009
[TBL] [Abstract][Full Text] [Related]
17. The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodies.
Van der Perren A; Gelders G; Fenyi A; Bousset L; Brito F; Peelaerts W; Van den Haute C; Gentleman S; Melki R; Baekelandt V
Acta Neuropathol; 2020 Jun; 139(6):977-1000. PubMed ID: 32356200
[TBL] [Abstract][Full Text] [Related]
18. Loss of A5 noradrenergic neurons in multiple system atrophy.
Benarroch EE; Schmeichel AM; Low PA; Sandroni P; Parisi JE
Acta Neuropathol; 2008 Jun; 115(6):629-34. PubMed ID: 18297292
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical localization of spatacsin in α-synucleinopathies.
Kuru S; Yoshida M; Tatsumi S; Mimuro M
Neuropathology; 2014 Apr; 34(2):135-9. PubMed ID: 24112408
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence and autoradiographic evaluation of tau PET ligand PBB3 to α-synuclein pathology.
Koga S; Ono M; Sahara N; Higuchi M; Dickson DW
Mov Disord; 2017 Jun; 32(6):884-892. PubMed ID: 28440890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
